Prestige Consumer Healthcare (PBH) Cash from Investing Activities (2010 - 2025)

Prestige Consumer Healthcare's Cash from Investing Activities history runs 16 years deep, the most recent figure standing at -$128.6 million for Q4 2025.

• In Q4 2025, Cash from Investing Activities fell 1209.7% year-over-year to -$128.6 million; the TTM figure through Dec 2025 stood at -$136.9 million (down 372.46% YoY), while the FY2025 annual figure was -$17.5 million, up 13.22% from the prior year.
• Cash from Investing Activities was -$128.6 million for Q4 2025 at Prestige Consumer Healthcare, down from -$2.9 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $2.3 million in Q2 2023 to a low of -$231.7 million in Q3 2021.
• Historically, Cash from Investing Activities has averaged -$22.2 million across 5 years, with a median of -$3.1 million in 2022.
• The sharpest annual moves came in 2021 and 2023: Cash from Investing Activities tumbled 2455.33% in 2021, then jumped 321.87% in 2023.
• A 5-year view of Cash from Investing Activities shows it stood at -$20.2 million in 2021, then surged by 91.09% to -$1.8 million in 2022, then sank by 149.36% to -$4.5 million in 2023, then sank by 118.33% to -$9.8 million in 2024, then tumbled by 1209.7% to -$128.6 million in 2025.
• The last three Cash from Investing Activities figures came in at -$128.6 million (Q4 2025), -$2.9 million (Q3 2025), and -$1.9 million (Q2 2025), per Business Quant data.